Literature DB >> 17374372

Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease.

Fabrice M A C Martens1, Yolanda van der Graaf, Joke M Dijk, Jobien K Olijhoek, Frank L J Visseren.   

Abstract

INTRODUCTION: Insulin resistance is generally considered to be of major importance in the pathophysiology of the metabolic syndrome and type 2 diabetes mellitus, both high-risk conditions for cardiovascular complications. Carotid artery stiffness is increasingly recognized as an important predictor of cardiovascular morbidity and mortality. Therefore, in the present study we determined whether the metabolic syndrome (MetSyn) and type 2 diabetes mellitus (DM2) are associated with carotid artery stiffness in patients with already clinical manifestations of arterial disease. METHODS AND
RESULTS: A cross-sectional study in 2105 patients with manifest arterial disease (cerebral, coronary or peripheral artery disease, renal artery stenosis or an aneurysm of the abdominal aorta) was performed. The difference in carotid stiffness between patients with and without MetSyn and with and without DM2 was studied with linear regression analysis. Compared to patients without DM2 (N=1112), patients with DM2 (N=301) had significantly higher arterial stiffness (distension -18.5 (-35.1;-1.9) 95% CI/distensibility -1.8 (-2.2;-1.4) 95% CI). Generally, there was a trend of higher carotid stiffness in patients with MetSyn (N=922) compared to patients without (N=1112) MetSyn (distension -9.6 (-21.5;2.3) 95% CI/distensibility -2.0 (-2.6;-1.4) 95% CI). Excluding the patients with also DM2 (N=230) from the MetSyn-group diminished this relation (distension -5.7 (-18.8;7.4) 95% CI/distensibility -1.1 (-1.6;-0.6) 95% CI). Furthermore, in the population as a whole, carotid artery stiffness increased with increasing number of components of the metabolic syndrome (p=0.08 for distension/p< or =0.001 for distensibility). In addition, this association was not as clear after exclusion of the patients with DM2 from the MetSyn-group (p=0.24 for distension/p<0.001 for distensibility). From all the components of the MetSyn only high blood pressure and high fasting glucose influenced the carotid artery stiffness.
CONCLUSIONS: We concluded that (increasing number of components of) the metabolic syndrome were associated with marginally higher carotid artery stiffness, while type 2 diabetes was associated with a marked increase in carotid artery stiffness, in patients with already clinical manifestations of arterial disease.

Entities:  

Mesh:

Year:  2007        PMID: 17374372     DOI: 10.1016/j.atherosclerosis.2007.02.019

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Carotid pulse wave velocity by magnetic resonance imaging is increased in middle-aged subjects with the metabolic syndrome.

Authors:  Gerard Blasco; Simone Balocco; Josep Puig; Javier Sánchez-González; Wifredo Ricart; Josep Daunis-i-Estadella; Xavier Molina; Salvador Pedraza; José Manuel Fernández-Real
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-26       Impact factor: 2.357

2.  Characterization of macro-and microvascular function and structure in patients with type 2 diabetes mellitus.

Authors:  Stefanie Keymel; Yvonne Heinen; Jan Balzer; Tienush Rassaf; Malte Kelm; Thomas Lauer; Christian Heiss
Journal:  Am J Cardiovasc Dis       Date:  2011-05-15

3.  Mitigation of diabetes-related complications in implanted collagen and elastin scaffolds using matrix-binding polyphenol.

Authors:  James P Chow; Dan T Simionescu; Harleigh Warner; Bo Wang; Sourav S Patnaik; Jun Liao; Agneta Simionescu
Journal:  Biomaterials       Date:  2012-10-24       Impact factor: 12.479

4.  Metabolic syndrome increases carotid artery stiffness: the Northern Manhattan Study.

Authors:  David Della-Morte; Hannah Gardener; Federica Denaro; Bernadette Boden-Albala; Mitchell S V Elkind; Myunghee C Paik; Ralph L Sacco; Tatjana Rundek
Journal:  Int J Stroke       Date:  2010-06       Impact factor: 5.266

5.  Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidity.

Authors:  Pajaree Lilitkarntakul; Neeraj Dhaun; Vanessa Melville; Debbie Kerr; David J Webb; Jane Goddard
Journal:  Diabetes Care       Date:  2012-05-29       Impact factor: 19.112

6.  Aortic stiffness in prediabetic adults: relationship to insulin resistance.

Authors:  Hamdy Sliem; Gamela Nasr
Journal:  J Clin Med Res       Date:  2010-03-09

7.  The effect of diabetes self-management education on body weight, glycemic control, and other metabolic markers in patients with type 2 diabetes mellitus.

Authors:  Chuang Yuan; Christopher W K Lai; Lawrence W C Chan; Meyrick Chow; Helen K W Law; Michael Ying
Journal:  J Diabetes Res       Date:  2014-07-17       Impact factor: 4.011

8.  The association between fasting serum insulin, apo-lipoproteins level, and severity of coronary artery involvement in non-diabetic patients.

Authors:  Jafar Golshahi; Ebrahim Validi; Mojtaba Akbari
Journal:  Adv Biomed Res       Date:  2014-09-12

9.  Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study.

Authors:  Jorge Escobedo; Herman Schargrodsky; Beatriz Champagne; Honorio Silva; Carlos P Boissonnet; Raul Vinueza; Marta Torres; Rafael Hernandez; Elinor Wilson
Journal:  Cardiovasc Diabetol       Date:  2009-09-26       Impact factor: 9.951

10.  Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus.

Authors:  Nicholas Tentolouris; Athanasia Papazafiropoulou; Ioannis Moyssakis; Stavros Liatis; Despoina Perrea; Maria Kostakis; Nicholas Katsilambros
Journal:  Cardiovasc Diabetol       Date:  2008-01-02       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.